<DOC>
	<DOCNO>NCT00710515</DOCNO>
	<brief_summary>The purpose study test level AZD6244 blood affect take food time capsule compare take capsule empty stomach</brief_summary>
	<brief_title>Study Assess Effect Dosing AZD6244 HydSulfate Presence Absence Food Patients With Advanced Solid Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Able eat high fat breakfast within 30minute period Advanced cancer refractory standard therapy , standard therapy exist WHO ECOG performance status 02 ( performance status 2 must stable deterioration 2 week ) Any radiotherapy chemotherapy within 21 day prior start study treatment ( include palliative radiotherapy focal site ) . Any evidence severe uncontrolled systemic disease ( eg. , severe hepatic impairment , severe renal impairment , uncontrolled diabetes , acute uncontrolled infection ) current unstable uncompensated respiratory cardiac condition peripheral vascular disease include diabetic vasculopathy . Refractory nausea vomiting , chronic GI disease ( eg. , inflammatory bowel disease ) significant bowel resection would preclude adequate absorption .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Phase I</keyword>
	<keyword>AZD6244</keyword>
</DOC>